260 related articles for article (PubMed ID: 7911827)
1. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.
Turjanski N; Sawle GV; Playford ED; Weeks R; Lammerstma AA; Lees AJ; Brooks DJ
J Neurol Neurosurg Psychiatry; 1994 Jun; 57(6):688-92. PubMed ID: 7911827
[TBL] [Abstract][Full Text] [Related]
2. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET.
Singer HS; Szymanski S; Giuliano J; Yokoi F; Dogan AS; Brasic JR; Zhou Y; Grace AA; Wong DF
Am J Psychiatry; 2002 Aug; 159(8):1329-36. PubMed ID: 12153825
[TBL] [Abstract][Full Text] [Related]
3. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
4. High presynaptic dopaminergic activity in children with Tourette's disorder.
Ernst M; Zametkin AJ; Jons PH; Matochik JA; Pascualvaca D; Cohen RM
J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):86-94. PubMed ID: 9893421
[TBL] [Abstract][Full Text] [Related]
5. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
Turjanski N; Lees AJ; Brooks DJ
Neurology; 1999 Mar; 52(5):932-7. PubMed ID: 10102408
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study.
Shinotoh H; Snow BJ; Chu NS; Huang CC; Lu CS; Lee C; Takahashi H; Calne DB
Neurology; 1997 Apr; 48(4):1053-6. PubMed ID: 9109899
[TBL] [Abstract][Full Text] [Related]
7. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
8. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
Antonini A; Schwarz J; Oertel WH; Beer HF; Madeja UD; Leenders KL
Neurology; 1994 Jul; 44(7):1325-9. PubMed ID: 8035939
[TBL] [Abstract][Full Text] [Related]
9. D2 receptor binding in dopa-responsive dystonia.
Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
[TBL] [Abstract][Full Text] [Related]
10. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome.
Singer HS; Hahn IH; Moran TH
Ann Neurol; 1991 Oct; 30(4):558-62. PubMed ID: 1838678
[TBL] [Abstract][Full Text] [Related]
11. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
[TBL] [Abstract][Full Text] [Related]
12. 6-[18F]fluoro-L-dopa uptake and [76Br]bromolisuride binding in the excitotoxically lesioned caudate-putamen of nonhuman primates studied using positron emission tomography.
Hantraye P; Loc'H C; Maziere B; Khalili-Varasteh M; Crouzel C; Fournier D; Yorke JC; Stulzaft O; Riche D; Isacson O
Exp Neurol; 1992 Feb; 115(2):218-27. PubMed ID: 1531196
[TBL] [Abstract][Full Text] [Related]
13. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride.
Rinne JO; Laihinen A; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Oikonen V; Rinne UK
J Neurol Sci; 1995 Oct; 132(2):156-61. PubMed ID: 8543941
[TBL] [Abstract][Full Text] [Related]
14. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.
Antonini A; Leenders KL
Ann N Y Acad Sci; 1993 Sep; 695():81-5. PubMed ID: 8239318
[TBL] [Abstract][Full Text] [Related]
16. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
[TBL] [Abstract][Full Text] [Related]
17. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome.
Meyer P; Bohnen NI; Minoshima S; Koeppe RA; Wernette K; Kilbourn MR; Kuhl DE; Frey KA; Albin RL
Neurology; 1999 Jul; 53(2):371-4. PubMed ID: 10430428
[TBL] [Abstract][Full Text] [Related]
18. Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and 11C-raclopride.
Khan N; Antonini A; Parkes D; Dahlitz MJ; Meier-Ewert K; Weindl A; Leenders KL
Neurology; 1994 Nov; 44(11):2102-4. PubMed ID: 7969966
[TBL] [Abstract][Full Text] [Related]
19. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study.
Brooks DJ; Ibanez V; Playford ED; Sawle GV; Leigh PN; Kocen RS; Harding AE; Marsden CD
Ann Neurol; 1991 Aug; 30(2):166-71. PubMed ID: 1897909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
